1st Quarter - Report — BIOCOM for BIOCOM (2019)

Firm

BIOCOM

Client

BIOCOM

Income

—

Expenses

$48,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Advocated for legislation to permanently repeal the medical device tax.

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Health Issues HCR

Held an advocacy fly-in to discuss the importance of digital health technologies, including funding, FDA and ONC regulations, reimbursement, and privacy and security considerations. Discussed drug pricing policies and their impact on innovation, including generic competition, reference pricing, price transparency, Medicare negotiation, protected classes, PBM rebates, and 340B reform. Advocated for the reauthorization of PAHPA.

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Encouraged Congress to end the government shutdown and highlighted the impact of the shutdown on FDA activities. Supported increased funding for NIH and FDA in FY2020 appropriations.

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: Patent & Trademark Office (PTO); SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Opposed legislation and policies that would undermine the US patent system, including "compulsory licenses" Hosted a roundtable with USPTO Director, Andrei Iancu Hosted a meeting with USPTO Director of Technology Center 3600, Tariq Hafiz

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.